The story of Viagra presents a complex case for investors in the drug sector. While initially a tremendous success, producing huge profits, the patent lapse and the subsequent entry of off-brand competitors have significantly impacted earnings. This presents questions about the ongoing profitability of similar medication projects and suggests th… Read More